Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival.

Wu, Cheng-Guang; Casanova, Ruben; Mairinger, Fabian; Soltermann, Alex

Wu, Cheng-Guang; Casanova, Ruben; Mairinger, Fabian; Soltermann, Alex.

Afiliação

Wu CG; Institute of Pathology, University Hospital Zurich, Zurich, Switzerland.
Casanova R; Institute of Pathology, University Hospital Zurich, Zurich, Switzerland.
Mairinger F; Institute of Pathology, University Hospital Essen, Essen, Germany.
Soltermann A; Facharzt Foederatio Medicorum Helveticorum (FMH) Pathologie, Pathologie Länggasse, Ittigen, Switzerland.

Front Oncol ; 12: 1031094, 2022.

Article em En | MEDLINE | ID: mdl-36267973

Palavras-chave

PD-L1; immune microenvironnement; immune profiling; lung cancer; malignant pleural effusions; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google